avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.6 | trans-acting transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp1 | mm10_v2_chr15_+_102406143_102406380 | -0.65 | 2.0e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_105269837 | 19.89 |
ENSMUST00000172525.1
ENSMUST00000174837.1 ENSMUST00000173859.1 |
Hsf4
|
heat shock transcription factor 4 |
chr8_+_105269788 | 19.52 |
ENSMUST00000036127.2
ENSMUST00000163734.2 |
Hsf4
|
heat shock transcription factor 4 |
chr1_+_74332596 | 19.24 |
ENSMUST00000087225.5
|
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr10_-_88503952 | 17.12 |
ENSMUST00000020253.8
|
Chpt1
|
choline phosphotransferase 1 |
chr2_+_58567360 | 16.68 |
ENSMUST00000071543.5
|
Upp2
|
uridine phosphorylase 2 |
chr19_+_46131888 | 16.30 |
ENSMUST00000043739.3
|
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr18_-_38211957 | 15.77 |
ENSMUST00000159405.1
ENSMUST00000160721.1 |
Pcdh1
|
protocadherin 1 |
chr12_+_108334341 | 15.36 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr12_-_84450944 | 15.14 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr11_-_120660565 | 15.12 |
ENSMUST00000106177.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr2_+_155517948 | 14.86 |
ENSMUST00000029135.8
ENSMUST00000065973.2 ENSMUST00000103142.5 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr7_-_99626936 | 14.65 |
ENSMUST00000178124.1
|
Gm4980
|
predicted gene 4980 |
chrX_+_36598199 | 14.58 |
ENSMUST00000073339.6
|
Pgrmc1
|
progesterone receptor membrane component 1 |
chr2_-_148045891 | 14.38 |
ENSMUST00000109964.1
|
Foxa2
|
forkhead box A2 |
chr10_-_88503912 | 14.07 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr17_-_45686120 | 13.95 |
ENSMUST00000143907.1
ENSMUST00000127065.1 |
Tmem63b
|
transmembrane protein 63b |
chrX_-_73716145 | 13.73 |
ENSMUST00000002091.5
|
Bcap31
|
B cell receptor associated protein 31 |
chr3_-_89393629 | 13.68 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr11_+_94211431 | 13.50 |
ENSMUST00000041589.5
|
Tob1
|
transducer of ErbB-2.1 |
chr17_-_57059795 | 13.33 |
ENSMUST00000040280.7
|
Slc25a23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
chr2_-_73386396 | 13.24 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr7_-_81454751 | 13.23 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr16_+_44173271 | 13.15 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr18_+_64340225 | 13.14 |
ENSMUST00000175965.2
ENSMUST00000115145.3 |
Onecut2
|
one cut domain, family member 2 |
chr17_-_45685973 | 12.86 |
ENSMUST00000145873.1
|
Tmem63b
|
transmembrane protein 63b |
chr10_+_80329953 | 12.71 |
ENSMUST00000105358.1
ENSMUST00000105357.1 ENSMUST00000105354.1 ENSMUST00000105355.1 |
Reep6
|
receptor accessory protein 6 |
chr7_+_44384098 | 12.69 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
chr10_-_88504073 | 12.64 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr8_+_114133601 | 12.48 |
ENSMUST00000109109.1
|
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr4_+_43046014 | 12.36 |
ENSMUST00000180426.1
|
Gm26881
|
predicted gene, 26881 |
chr16_+_44173239 | 12.15 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr4_-_114908892 | 11.99 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr7_-_43489967 | 11.97 |
ENSMUST00000107974.1
|
Iglon5
|
IgLON family member 5 |
chr3_-_18243289 | 11.87 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr9_+_47530173 | 11.60 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr11_-_102296618 | 11.51 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr5_-_53213447 | 11.18 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr16_-_24393588 | 11.08 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr5_+_129941949 | 11.02 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr7_+_44590886 | 11.01 |
ENSMUST00000107906.3
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chrX_-_60403947 | 10.82 |
ENSMUST00000033480.6
ENSMUST00000101527.2 |
Atp11c
|
ATPase, class VI, type 11C |
chr16_-_46496772 | 10.81 |
ENSMUST00000149901.1
ENSMUST00000096052.2 |
Pvrl3
|
poliovirus receptor-related 3 |
chr11_-_120661175 | 10.77 |
ENSMUST00000150458.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr4_-_41503046 | 10.74 |
ENSMUST00000054920.4
|
AI464131
|
expressed sequence AI464131 |
chr1_+_72824482 | 10.70 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr11_+_90249469 | 10.69 |
ENSMUST00000004050.6
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr12_+_8771317 | 10.46 |
ENSMUST00000020911.7
|
Sdc1
|
syndecan 1 |
chr13_+_54789500 | 10.42 |
ENSMUST00000163915.1
ENSMUST00000099503.3 ENSMUST00000171859.1 |
Tspan17
|
tetraspanin 17 |
chr9_-_110742577 | 10.35 |
ENSMUST00000006005.7
|
Pth1r
|
parathyroid hormone 1 receptor |
chr1_+_133363564 | 10.02 |
ENSMUST00000135222.2
|
Etnk2
|
ethanolamine kinase 2 |
chr11_+_119942763 | 10.02 |
ENSMUST00000026436.3
ENSMUST00000106231.1 ENSMUST00000075180.5 ENSMUST00000103021.3 ENSMUST00000106233.1 |
Baiap2
|
brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr19_+_37697792 | 9.95 |
ENSMUST00000025946.5
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1 |
chr5_+_134986191 | 9.82 |
ENSMUST00000094245.2
|
Cldn3
|
claudin 3 |
chr4_-_41640322 | 9.72 |
ENSMUST00000127306.1
|
Enho
|
energy homeostasis associated |
chr11_+_90249426 | 9.70 |
ENSMUST00000107887.1
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr11_+_101468164 | 9.61 |
ENSMUST00000001347.6
|
Rnd2
|
Rho family GTPase 2 |
chr10_+_63024315 | 9.55 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr7_+_57591147 | 9.55 |
ENSMUST00000039697.7
|
Gabrb3
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
chr13_+_54789377 | 9.47 |
ENSMUST00000026993.7
ENSMUST00000131692.2 ENSMUST00000163796.1 |
Tspan17
|
tetraspanin 17 |
chr3_-_89393294 | 9.46 |
ENSMUST00000142119.1
ENSMUST00000029677.8 ENSMUST00000148361.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr6_-_119848059 | 9.45 |
ENSMUST00000184864.1
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr4_-_46991842 | 9.40 |
ENSMUST00000107749.2
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr12_+_8771405 | 9.38 |
ENSMUST00000171158.1
|
Sdc1
|
syndecan 1 |
chr17_-_45686214 | 9.38 |
ENSMUST00000113523.2
|
Tmem63b
|
transmembrane protein 63b |
chr5_-_65435717 | 9.36 |
ENSMUST00000117542.1
|
Ugdh
|
UDP-glucose dehydrogenase |
chr9_-_108263887 | 9.21 |
ENSMUST00000166905.1
ENSMUST00000080435.2 |
Dag1
|
dystroglycan 1 |
chr7_+_28180226 | 9.13 |
ENSMUST00000172467.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr6_-_120294559 | 9.08 |
ENSMUST00000057283.7
|
B4galnt3
|
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
chr13_-_47043116 | 9.01 |
ENSMUST00000110118.1
ENSMUST00000124948.1 ENSMUST00000021806.3 ENSMUST00000136864.1 |
Tpmt
|
thiopurine methyltransferase |
chr10_+_128194631 | 9.00 |
ENSMUST00000123291.1
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr4_-_129239165 | 8.98 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr8_+_76902277 | 8.95 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr2_-_160872985 | 8.94 |
ENSMUST00000109460.1
ENSMUST00000127201.1 |
Zhx3
|
zinc fingers and homeoboxes 3 |
chr17_-_24209377 | 8.88 |
ENSMUST00000024931.4
|
Ntn3
|
netrin 3 |
chr9_+_121642716 | 8.85 |
ENSMUST00000035115.4
|
Vipr1
|
vasoactive intestinal peptide receptor 1 |
chr16_+_20733104 | 8.81 |
ENSMUST00000115423.1
ENSMUST00000007171.6 |
Chrd
|
chordin |
chr7_+_28180272 | 8.80 |
ENSMUST00000173223.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr12_+_103532435 | 8.76 |
ENSMUST00000021631.5
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr5_+_73491026 | 8.75 |
ENSMUST00000063882.5
ENSMUST00000113558.1 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr10_+_128933782 | 8.69 |
ENSMUST00000099112.2
|
Itga7
|
integrin alpha 7 |
chr14_-_25769033 | 8.68 |
ENSMUST00000069180.7
|
Zcchc24
|
zinc finger, CCHC domain containing 24 |
chr2_-_160872829 | 8.63 |
ENSMUST00000176141.1
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr13_+_12565868 | 8.62 |
ENSMUST00000071973.6
|
Ero1lb
|
ERO1-like beta (S. cerevisiae) |
chr14_-_33447142 | 8.56 |
ENSMUST00000111944.3
ENSMUST00000022504.5 ENSMUST00000111945.2 |
Mapk8
|
mitogen-activated protein kinase 8 |
chr4_+_116877376 | 8.51 |
ENSMUST00000044823.3
|
Zswim5
|
zinc finger SWIM-type containing 5 |
chr7_+_44384604 | 8.50 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr19_-_4943049 | 8.44 |
ENSMUST00000133254.1
ENSMUST00000120475.1 ENSMUST00000025834.7 |
Peli3
|
pellino 3 |
chr7_-_19699008 | 8.28 |
ENSMUST00000174355.1
ENSMUST00000172983.1 ENSMUST00000174710.1 ENSMUST00000167646.2 ENSMUST00000003066.9 ENSMUST00000174064.1 |
Apoe
|
apolipoprotein E |
chr1_-_93478785 | 8.28 |
ENSMUST00000170883.1
|
Hdlbp
|
high density lipoprotein (HDL) binding protein |
chr15_-_100599983 | 8.28 |
ENSMUST00000073837.6
|
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chr6_-_119848120 | 8.27 |
ENSMUST00000183703.1
ENSMUST00000183911.1 |
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr4_+_117252010 | 8.25 |
ENSMUST00000125943.1
ENSMUST00000106434.1 |
Tmem53
|
transmembrane protein 53 |
chr19_+_44989073 | 8.25 |
ENSMUST00000026225.8
|
Sema4g
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
chr7_-_16614937 | 8.25 |
ENSMUST00000171937.1
ENSMUST00000075845.4 |
Grlf1
|
glucocorticoid receptor DNA binding factor 1 |
chr11_-_87987528 | 8.24 |
ENSMUST00000020775.2
|
Dynll2
|
dynein light chain LC8-type 2 |
chrX_+_161717498 | 8.18 |
ENSMUST00000061514.7
|
Rai2
|
retinoic acid induced 2 |
chr10_+_128194446 | 8.18 |
ENSMUST00000044776.6
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr6_-_124917939 | 8.17 |
ENSMUST00000032216.6
|
Ptms
|
parathymosin |
chrX_-_160994665 | 8.16 |
ENSMUST00000087104.4
|
Cdkl5
|
cyclin-dependent kinase-like 5 |
chr11_+_98348404 | 8.16 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr4_+_117251951 | 8.14 |
ENSMUST00000062824.5
|
Tmem53
|
transmembrane protein 53 |
chr11_-_74925925 | 8.01 |
ENSMUST00000121738.1
|
Srr
|
serine racemase |
chr8_+_114133557 | 7.98 |
ENSMUST00000073521.5
ENSMUST00000066514.6 |
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr9_+_37613806 | 7.97 |
ENSMUST00000002007.3
|
Siae
|
sialic acid acetylesterase |
chr7_-_100658394 | 7.97 |
ENSMUST00000138830.1
ENSMUST00000107044.3 ENSMUST00000116287.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr6_-_146502099 | 7.93 |
ENSMUST00000053273.8
|
Itpr2
|
inositol 1,4,5-triphosphate receptor 2 |
chr19_-_46148369 | 7.91 |
ENSMUST00000026259.9
|
Pitx3
|
paired-like homeodomain transcription factor 3 |
chr2_-_160872552 | 7.87 |
ENSMUST00000103111.2
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr2_-_130642770 | 7.84 |
ENSMUST00000045761.6
|
Lzts3
|
leucine zipper, putative tumor suppressor family member 3 |
chr9_+_55326913 | 7.81 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr10_-_127620960 | 7.80 |
ENSMUST00000121829.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr7_-_27333602 | 7.79 |
ENSMUST00000118583.1
ENSMUST00000118961.1 ENSMUST00000121175.1 |
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr15_-_31367527 | 7.75 |
ENSMUST00000076942.4
ENSMUST00000123325.1 ENSMUST00000110410.2 |
Ankrd33b
|
ankyrin repeat domain 33B |
chr5_-_31295862 | 7.74 |
ENSMUST00000041266.7
ENSMUST00000172435.1 |
Fndc4
|
fibronectin type III domain containing 4 |
chr9_-_108263706 | 7.72 |
ENSMUST00000171412.1
|
Dag1
|
dystroglycan 1 |
chr11_+_102393403 | 7.70 |
ENSMUST00000107105.2
ENSMUST00000107102.1 ENSMUST00000107103.1 ENSMUST00000006750.7 |
Rundc3a
|
RUN domain containing 3A |
chr10_-_127620922 | 7.69 |
ENSMUST00000118455.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr1_-_121328024 | 7.69 |
ENSMUST00000003818.7
|
Insig2
|
insulin induced gene 2 |
chr15_-_86033777 | 7.68 |
ENSMUST00000016172.7
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) |
chr5_-_65435881 | 7.66 |
ENSMUST00000031103.7
|
Ugdh
|
UDP-glucose dehydrogenase |
chr7_-_100658364 | 7.66 |
ENSMUST00000107043.1
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr4_+_148130883 | 7.65 |
ENSMUST00000084129.2
|
Mad2l2
|
MAD2 mitotic arrest deficient-like 2 |
chr7_+_97332311 | 7.65 |
ENSMUST00000054107.5
|
Kctd21
|
potassium channel tetramerisation domain containing 21 |
chr12_-_108275409 | 7.61 |
ENSMUST00000136175.1
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr9_+_80165079 | 7.61 |
ENSMUST00000184480.1
|
Myo6
|
myosin VI |
chr11_+_55098104 | 7.58 |
ENSMUST00000000608.7
|
Gm2a
|
GM2 ganglioside activator protein |
chr9_+_57697612 | 7.58 |
ENSMUST00000034865.4
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1 |
chr8_-_91801948 | 7.55 |
ENSMUST00000175795.1
|
Irx3
|
Iroquois related homeobox 3 (Drosophila) |
chr7_-_140154712 | 7.53 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr18_+_84088077 | 7.52 |
ENSMUST00000060223.2
|
Zadh2
|
zinc binding alcohol dehydrogenase, domain containing 2 |
chrX_+_73716577 | 7.48 |
ENSMUST00000002084.7
|
Abcd1
|
ATP-binding cassette, sub-family D (ALD), member 1 |
chr3_-_89322883 | 7.47 |
ENSMUST00000029673.5
|
Efna3
|
ephrin A3 |
chr14_+_21052574 | 7.38 |
ENSMUST00000045376.9
|
Adk
|
adenosine kinase |
chr4_-_107307118 | 7.38 |
ENSMUST00000126291.1
ENSMUST00000106748.1 ENSMUST00000129138.1 ENSMUST00000082426.3 |
Dio1
|
deiodinase, iodothyronine, type I |
chr14_+_55575617 | 7.38 |
ENSMUST00000022826.5
|
Fitm1
|
fat storage-inducing transmembrane protein 1 |
chr12_+_108792946 | 7.38 |
ENSMUST00000021692.7
|
Yy1
|
YY1 transcription factor |
chr7_-_30924169 | 7.36 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr7_-_34654342 | 7.35 |
ENSMUST00000108069.1
|
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chr16_-_46496955 | 7.32 |
ENSMUST00000023335.6
ENSMUST00000023334.8 |
Pvrl3
|
poliovirus receptor-related 3 |
chr15_+_99295087 | 7.28 |
ENSMUST00000128352.1
ENSMUST00000145482.1 |
Prpf40b
|
PRP40 pre-mRNA processing factor 40 homolog B (yeast) |
chr2_-_168741752 | 7.26 |
ENSMUST00000029060.4
|
Atp9a
|
ATPase, class II, type 9A |
chr2_+_31470207 | 7.22 |
ENSMUST00000102840.4
|
Ass1
|
argininosuccinate synthetase 1 |
chr16_-_17928136 | 7.20 |
ENSMUST00000003622.8
|
Slc25a1
|
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
chr2_-_33371400 | 7.18 |
ENSMUST00000113164.1
ENSMUST00000091039.2 ENSMUST00000042615.6 |
Ralgps1
|
Ral GEF with PH domain and SH3 binding motif 1 |
chr6_-_119848093 | 7.15 |
ENSMUST00000079582.4
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr4_-_108118504 | 7.12 |
ENSMUST00000149106.1
|
Scp2
|
sterol carrier protein 2, liver |
chr16_+_64851991 | 7.11 |
ENSMUST00000067744.7
|
Cggbp1
|
CGG triplet repeat binding protein 1 |
chr18_-_61911783 | 7.09 |
ENSMUST00000049378.8
ENSMUST00000166783.1 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr13_-_29984219 | 7.06 |
ENSMUST00000146092.1
|
E2f3
|
E2F transcription factor 3 |
chr15_+_76696725 | 7.05 |
ENSMUST00000023203.4
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr8_-_84800024 | 7.05 |
ENSMUST00000126806.1
ENSMUST00000076715.6 |
Nfix
|
nuclear factor I/X |
chr14_+_55560904 | 6.99 |
ENSMUST00000072530.4
ENSMUST00000128490.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr10_+_127380591 | 6.97 |
ENSMUST00000166820.1
|
R3hdm2
|
R3H domain containing 2 |
chr18_-_3337539 | 6.96 |
ENSMUST00000142690.1
ENSMUST00000025069.4 ENSMUST00000082141.5 ENSMUST00000165086.1 ENSMUST00000149803.1 |
Crem
|
cAMP responsive element modulator |
chrX_-_162888426 | 6.96 |
ENSMUST00000033723.3
|
Syap1
|
synapse associated protein 1 |
chr11_-_74925658 | 6.96 |
ENSMUST00000138612.1
ENSMUST00000123855.1 ENSMUST00000128556.1 ENSMUST00000108448.1 ENSMUST00000108447.1 ENSMUST00000065211.2 |
Srr
|
serine racemase |
chr15_-_3583146 | 6.88 |
ENSMUST00000110698.2
|
Ghr
|
growth hormone receptor |
chr16_-_20621255 | 6.88 |
ENSMUST00000052939.2
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr9_-_31211805 | 6.85 |
ENSMUST00000072634.7
ENSMUST00000079758.7 |
Aplp2
|
amyloid beta (A4) precursor-like protein 2 |
chr2_-_65022740 | 6.83 |
ENSMUST00000028252.7
|
Grb14
|
growth factor receptor bound protein 14 |
chr19_+_53903351 | 6.81 |
ENSMUST00000025931.6
ENSMUST00000165617.1 |
Pdcd4
|
programmed cell death 4 |
chr11_+_75193783 | 6.77 |
ENSMUST00000102514.3
|
Rtn4rl1
|
reticulon 4 receptor-like 1 |
chr1_-_65179058 | 6.75 |
ENSMUST00000097709.4
|
Idh1
|
isocitrate dehydrogenase 1 (NADP+), soluble |
chrX_+_161717055 | 6.74 |
ENSMUST00000112338.1
|
Rai2
|
retinoic acid induced 2 |
chr5_+_65107551 | 6.73 |
ENSMUST00000101192.2
|
Klhl5
|
kelch-like 5 |
chr6_-_48445373 | 6.72 |
ENSMUST00000114563.1
ENSMUST00000114558.1 ENSMUST00000101443.3 ENSMUST00000114564.1 |
Zfp467
|
zinc finger protein 467 |
chr17_-_28350747 | 6.72 |
ENSMUST00000080572.7
ENSMUST00000156862.1 |
Tead3
|
TEA domain family member 3 |
chr7_+_101321079 | 6.70 |
ENSMUST00000032927.7
|
Stard10
|
START domain containing 10 |
chr19_-_47464406 | 6.69 |
ENSMUST00000111800.2
ENSMUST00000081619.2 |
Sh3pxd2a
|
SH3 and PX domains 2A |
chr17_+_24736639 | 6.66 |
ENSMUST00000115262.1
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr10_-_109010955 | 6.66 |
ENSMUST00000105276.1
ENSMUST00000064054.7 |
Syt1
|
synaptotagmin I |
chr10_+_80330127 | 6.64 |
ENSMUST00000040081.6
|
Reep6
|
receptor accessory protein 6 |
chr19_-_6980420 | 6.62 |
ENSMUST00000070878.8
ENSMUST00000177752.1 |
Fkbp2
|
FK506 binding protein 2 |
chr4_+_155563700 | 6.61 |
ENSMUST00000105613.3
ENSMUST00000143840.1 ENSMUST00000146080.1 |
Nadk
|
NAD kinase |
chr5_+_130448801 | 6.61 |
ENSMUST00000111288.2
|
Caln1
|
calneuron 1 |
chr11_+_77462605 | 6.61 |
ENSMUST00000130255.1
|
Coro6
|
coronin 6 |
chr9_+_77754526 | 6.60 |
ENSMUST00000034905.8
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr10_-_59616667 | 6.60 |
ENSMUST00000020312.6
|
Mcu
|
mitochondrial calcium uniporter |
chr15_-_75566608 | 6.57 |
ENSMUST00000163116.1
ENSMUST00000023241.5 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr6_+_138140298 | 6.56 |
ENSMUST00000008684.4
|
Mgst1
|
microsomal glutathione S-transferase 1 |
chr3_+_118562129 | 6.56 |
ENSMUST00000039177.7
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr13_-_17694729 | 6.56 |
ENSMUST00000068545.4
|
5033411D12Rik
|
RIKEN cDNA 5033411D12 gene |
chr4_-_129248431 | 6.51 |
ENSMUST00000052602.5
|
C77080
|
expressed sequence C77080 |
chr9_+_119402444 | 6.51 |
ENSMUST00000035093.8
ENSMUST00000165044.1 |
Acvr2b
|
activin receptor IIB |
chr15_+_7129557 | 6.48 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr7_-_97579382 | 6.48 |
ENSMUST00000151840.1
ENSMUST00000135998.1 ENSMUST00000144858.1 ENSMUST00000146605.1 ENSMUST00000072725.5 ENSMUST00000138060.1 ENSMUST00000154853.1 ENSMUST00000136757.1 ENSMUST00000124552.1 |
Aamdc
|
adipogenesis associated Mth938 domain containing |
chr15_-_76660108 | 6.47 |
ENSMUST00000066677.8
ENSMUST00000177359.1 |
Cyhr1
|
cysteine and histidine rich 1 |
chr6_+_138140521 | 6.46 |
ENSMUST00000120939.1
ENSMUST00000120302.1 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr18_-_56562187 | 6.45 |
ENSMUST00000171844.2
|
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr5_-_34187670 | 6.45 |
ENSMUST00000042701.6
ENSMUST00000119171.1 |
Mxd4
|
Max dimerization protein 4 |
chr12_-_30373358 | 6.42 |
ENSMUST00000021004.7
|
Sntg2
|
syntrophin, gamma 2 |
chr1_+_93512079 | 6.41 |
ENSMUST00000120301.1
ENSMUST00000041983.4 ENSMUST00000122402.1 |
Farp2
|
FERM, RhoGEF and pleckstrin domain protein 2 |
chr1_-_173367638 | 6.38 |
ENSMUST00000005470.4
ENSMUST00000111220.1 |
Cadm3
|
cell adhesion molecule 3 |
chr11_-_72266596 | 6.38 |
ENSMUST00000021161.6
ENSMUST00000140167.1 |
Slc13a5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
chr17_+_45686322 | 6.37 |
ENSMUST00000024734.7
|
Mrpl14
|
mitochondrial ribosomal protein L14 |
chr5_+_30814722 | 6.35 |
ENSMUST00000114724.1
|
Mapre3
|
microtubule-associated protein, RP/EB family, member 3 |
chr19_+_6497772 | 6.34 |
ENSMUST00000113458.1
ENSMUST00000113459.1 |
Nrxn2
|
neurexin II |
chr9_-_107667375 | 6.31 |
ENSMUST00000010208.8
|
Slc38a3
|
solute carrier family 38, member 3 |
chr9_+_119357381 | 6.30 |
ENSMUST00000039610.8
|
Xylb
|
xylulokinase homolog (H. influenzae) |
chr15_+_81811414 | 6.29 |
ENSMUST00000023024.7
|
Tef
|
thyrotroph embryonic factor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 25.9 | GO:0006507 | GPI anchor release(GO:0006507) |
7.4 | 44.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
7.2 | 21.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
6.8 | 27.4 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
6.7 | 26.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
6.1 | 18.2 | GO:0048627 | myoblast development(GO:0048627) |
5.9 | 17.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
5.6 | 22.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
5.5 | 16.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
5.3 | 16.0 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
4.7 | 14.0 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
4.7 | 18.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
4.4 | 13.3 | GO:0097274 | urea homeostasis(GO:0097274) |
4.4 | 13.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
4.4 | 13.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
4.4 | 4.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
4.3 | 12.9 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
4.2 | 16.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
4.2 | 12.7 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
3.9 | 11.7 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
3.8 | 11.4 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) |
3.7 | 11.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
3.7 | 14.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
3.6 | 10.8 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
3.5 | 14.0 | GO:0061625 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
3.5 | 13.9 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
3.5 | 10.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
3.4 | 13.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
3.4 | 10.2 | GO:0070602 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
3.4 | 10.1 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
3.3 | 13.3 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
3.3 | 13.1 | GO:0030091 | protein repair(GO:0030091) |
3.3 | 9.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.3 | 13.0 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
3.2 | 16.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.2 | 3.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
3.1 | 9.2 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
3.0 | 12.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.0 | 9.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
3.0 | 11.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
2.9 | 25.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.9 | 8.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
2.9 | 5.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.9 | 8.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
2.8 | 28.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
2.7 | 8.2 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
2.6 | 7.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.6 | 2.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
2.5 | 7.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.5 | 7.5 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
2.5 | 7.5 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
2.5 | 7.5 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
2.5 | 12.5 | GO:0070178 | D-serine metabolic process(GO:0070178) |
2.4 | 7.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.4 | 9.6 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
2.4 | 7.2 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
2.4 | 2.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
2.4 | 2.4 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
2.4 | 9.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
2.4 | 4.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
2.3 | 7.0 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
2.3 | 2.3 | GO:0015744 | succinate transport(GO:0015744) |
2.3 | 6.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
2.3 | 6.8 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
2.3 | 9.0 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
2.3 | 15.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
2.2 | 11.1 | GO:0015888 | thiamine transport(GO:0015888) |
2.2 | 13.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.2 | 2.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
2.2 | 13.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
2.2 | 15.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.2 | 10.9 | GO:0051012 | microtubule sliding(GO:0051012) |
2.2 | 10.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.2 | 13.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
2.2 | 8.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.2 | 6.5 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
2.2 | 10.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.1 | 40.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
2.1 | 14.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.1 | 8.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.1 | 10.4 | GO:0070459 | prolactin secretion(GO:0070459) |
2.1 | 6.2 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
2.0 | 6.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
2.0 | 14.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.0 | 8.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
2.0 | 6.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.0 | 12.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.0 | 8.0 | GO:0030070 | insulin processing(GO:0030070) |
2.0 | 6.0 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.0 | 7.9 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
2.0 | 45.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
2.0 | 3.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.0 | 9.8 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
2.0 | 5.9 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
1.9 | 1.9 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
1.9 | 5.8 | GO:0015866 | ADP transport(GO:0015866) |
1.9 | 5.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.9 | 5.7 | GO:0001192 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
1.9 | 22.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.9 | 5.7 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.9 | 7.5 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.9 | 5.6 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.9 | 3.7 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.9 | 7.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.9 | 5.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.9 | 24.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.8 | 5.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.8 | 11.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.8 | 12.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
1.8 | 20.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.8 | 5.5 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.8 | 3.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.8 | 5.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.8 | 1.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.8 | 10.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.8 | 5.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.8 | 8.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.8 | 12.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.8 | 3.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
1.8 | 12.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.8 | 5.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
1.7 | 1.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.7 | 8.7 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
1.7 | 5.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.7 | 36.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.7 | 12.1 | GO:0001757 | somite specification(GO:0001757) |
1.7 | 13.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.7 | 6.9 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.7 | 13.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.7 | 8.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.7 | 8.6 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.7 | 5.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
1.7 | 5.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.7 | 16.9 | GO:0046449 | creatinine metabolic process(GO:0046449) |
1.7 | 5.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
1.7 | 8.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.7 | 6.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.7 | 16.5 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
1.7 | 5.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.6 | 11.4 | GO:0034214 | protein hexamerization(GO:0034214) |
1.6 | 4.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.6 | 13.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.6 | 3.2 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.6 | 1.6 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
1.6 | 1.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.6 | 8.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.6 | 8.0 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
1.6 | 11.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.6 | 3.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.6 | 6.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.6 | 22.0 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
1.6 | 4.7 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.6 | 9.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
1.6 | 4.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.6 | 3.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.6 | 7.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.6 | 14.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.5 | 10.8 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
1.5 | 4.6 | GO:1902022 | L-lysine transport(GO:1902022) |
1.5 | 4.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
1.5 | 3.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.5 | 26.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.5 | 4.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.5 | 4.6 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
1.5 | 6.0 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
1.5 | 13.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
1.5 | 4.5 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.5 | 3.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 5.9 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
1.5 | 13.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.5 | 11.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.4 | 4.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
1.4 | 2.9 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
1.4 | 1.4 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
1.4 | 5.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.4 | 11.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
1.4 | 4.2 | GO:0010949 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
1.4 | 5.6 | GO:0000050 | urea cycle(GO:0000050) |
1.4 | 7.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
1.4 | 5.6 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
1.4 | 1.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.4 | 8.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
1.4 | 5.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.4 | 2.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.4 | 5.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
1.4 | 27.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.4 | 1.4 | GO:0060596 | mammary placode formation(GO:0060596) |
1.3 | 10.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.3 | 5.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.3 | 8.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.3 | 5.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
1.3 | 5.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.3 | 6.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
1.3 | 4.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.3 | 4.0 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
1.3 | 2.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.3 | 6.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.3 | 9.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.3 | 3.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
1.3 | 6.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.3 | 9.1 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 2.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.3 | 1.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.3 | 22.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.3 | 3.9 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 9.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.3 | 2.6 | GO:0021759 | globus pallidus development(GO:0021759) |
1.3 | 19.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
1.3 | 2.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.3 | 3.8 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.3 | 7.7 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.3 | 6.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
1.3 | 8.9 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
1.3 | 3.8 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
1.3 | 2.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.3 | 15.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.3 | 10.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.3 | 3.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
1.3 | 5.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.3 | 8.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.3 | 3.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 5.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.2 | 6.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 12.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.2 | 4.9 | GO:0014028 | notochord formation(GO:0014028) |
1.2 | 3.7 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.2 | 9.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.2 | 7.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 19.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.2 | 12.2 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
1.2 | 8.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
1.2 | 2.4 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
1.2 | 6.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.2 | 3.6 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
1.2 | 3.6 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.2 | 4.8 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
1.2 | 3.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.2 | 11.9 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.2 | 4.8 | GO:0003360 | brainstem development(GO:0003360) |
1.2 | 4.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 4.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.2 | 2.4 | GO:0035973 | aggrephagy(GO:0035973) |
1.2 | 27.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 3.5 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
1.2 | 3.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 13.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.2 | 1.2 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.2 | 5.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
1.2 | 3.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.2 | 2.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.2 | 2.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
1.2 | 7.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.2 | 3.5 | GO:2000830 | vacuolar phosphate transport(GO:0007037) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of parathyroid hormone secretion(GO:2000830) |
1.2 | 3.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.2 | 2.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
1.2 | 9.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.1 | 18.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.1 | 5.7 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.1 | 14.9 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
1.1 | 8.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.1 | 4.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.1 | 8.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.1 | 4.5 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.1 | 4.5 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
1.1 | 3.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
1.1 | 4.5 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
1.1 | 4.5 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
1.1 | 7.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.1 | 4.5 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) |
1.1 | 2.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.1 | 4.5 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
1.1 | 8.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.1 | 5.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.1 | 4.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.1 | 10.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.1 | 4.4 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
1.1 | 4.4 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.1 | 6.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 2.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.1 | 2.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.1 | 3.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
1.1 | 3.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.1 | 6.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.1 | 4.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
1.1 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.1 | 7.6 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
1.1 | 4.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 10.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.1 | 5.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.1 | 2.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
1.1 | 2.2 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.1 | 5.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
1.1 | 17.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.1 | 37.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 28.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
1.1 | 3.2 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
1.1 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 11.7 | GO:0090003 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
1.1 | 3.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 2.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.1 | 2.1 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
1.1 | 8.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.0 | 4.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 4.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.0 | 8.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.0 | 5.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.0 | 1.0 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.0 | 1.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 7.1 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 4.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.0 | 2.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.0 | 1.0 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.0 | 15.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.0 | 2.0 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
1.0 | 1.0 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
1.0 | 4.0 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.0 | 5.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.0 | 1.0 | GO:0046710 | GDP metabolic process(GO:0046710) |
1.0 | 5.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.0 | 3.0 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
1.0 | 7.9 | GO:0071569 | protein ufmylation(GO:0071569) |
1.0 | 12.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.0 | 2.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.0 | 8.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.0 | 3.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.0 | 8.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.0 | 3.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.0 | 7.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.0 | 1.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.0 | 14.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.0 | 9.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.0 | 2.9 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
1.0 | 2.9 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
1.0 | 1.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.0 | 1.0 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
1.0 | 2.9 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.9 | 6.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 2.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.9 | 7.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.9 | 4.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.9 | 5.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 2.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.9 | 3.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.9 | 2.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.9 | 3.7 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.9 | 8.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.9 | 2.8 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.9 | 2.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.9 | 1.9 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.9 | 0.9 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.9 | 2.8 | GO:0015881 | creatine transport(GO:0015881) |
0.9 | 3.7 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.9 | 10.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.9 | 1.8 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.9 | 3.7 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
0.9 | 4.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.9 | 1.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.9 | 2.7 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.9 | 1.8 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.9 | 4.5 | GO:1990839 | response to endothelin(GO:1990839) |
0.9 | 2.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.9 | 1.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.9 | 4.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.9 | 3.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.9 | 1.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.9 | 8.9 | GO:0046959 | habituation(GO:0046959) |
0.9 | 1.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.9 | 4.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 2.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.9 | 3.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 10.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.9 | 5.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.9 | 5.2 | GO:0015705 | iodide transport(GO:0015705) |
0.9 | 9.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.9 | 4.3 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.9 | 2.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.9 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.9 | 2.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 2.6 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.8 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.8 | 1.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.8 | 5.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.8 | 9.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.8 | 0.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.8 | 6.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.8 | 5.9 | GO:0015862 | uridine transport(GO:0015862) |
0.8 | 12.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.8 | 3.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.8 | 2.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 14.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.8 | 5.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 2.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.8 | 3.3 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.8 | 2.5 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.8 | 4.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.8 | 4.9 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.8 | 4.9 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.8 | 6.5 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.8 | 7.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.8 | 2.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.8 | 1.6 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.8 | 34.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.8 | 4.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.8 | 13.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.8 | 3.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.8 | 4.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.8 | 6.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 5.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 8.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 2.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.8 | 4.0 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.8 | 0.8 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 3.2 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.8 | 1.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.8 | 5.6 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.8 | 0.8 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.8 | 4.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.8 | 3.9 | GO:0060430 | lung saccule development(GO:0060430) |
0.8 | 1.6 | GO:0015817 | histidine transport(GO:0015817) |
0.8 | 0.8 | GO:0048597 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.8 | 12.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.8 | 2.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 3.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.8 | 1.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.8 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 2.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.8 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 1.5 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.8 | 1.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.8 | 3.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.8 | 13.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.8 | 1.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.8 | 3.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.8 | 0.8 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.8 | 3.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.7 | 3.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.7 | 3.7 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.7 | 9.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.7 | 0.7 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.7 | 1.5 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.7 | 3.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.7 | 4.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.7 | 2.2 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.7 | 4.3 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.7 | 7.2 | GO:0055093 | response to hyperoxia(GO:0055093) |
0.7 | 15.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.7 | 6.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.7 | 2.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.7 | 6.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.7 | 3.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 2.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 2.9 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.7 | 1.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.7 | 0.7 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.7 | 9.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.7 | 5.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 0.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 1.4 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.7 | 7.8 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.7 | 7.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.7 | 0.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.7 | 2.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.7 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.7 | 3.5 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.7 | 4.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.7 | 0.7 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.7 | 4.8 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.7 | 2.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.7 | 9.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.7 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.7 | 10.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 2.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.7 | 2.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.7 | 2.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.7 | 2.0 | GO:0006983 | ER overload response(GO:0006983) |
0.7 | 3.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 4.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.7 | 1.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.7 | 1.3 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.7 | 2.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 4.7 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.7 | 3.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.7 | 7.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.7 | 2.7 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.7 | 1.3 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.7 | 1.3 | GO:0015755 | fructose transport(GO:0015755) |
0.7 | 2.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.7 | 1.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.7 | 2.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 4.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.7 | 2.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.7 | 2.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 7.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.7 | 5.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.7 | 2.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.7 | 3.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.7 | 2.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.7 | 0.7 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.7 | 22.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.6 | 8.4 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.6 | 14.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.6 | 1.3 | GO:0060592 | mammary gland formation(GO:0060592) |
0.6 | 0.6 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.6 | 3.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 2.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 1.9 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.6 | 3.2 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.6 | 3.2 | GO:0061086 | <